Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV ⩾ 100 cc-Reference-Cited by-同舟云学术

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV ⩾ 100 cc

Published:2017-02 Issue:2 Volume:122 Page:281-285
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Onimaru Rikiya,Onishi Hiroshi,Shibata Taro,Hiraoka Masahiro,Ishikura Satoshi,Karasawa Katsuyuki,Matsuo Yukinori,Kokubo Masaki,Shioyama Yoshiyuki,Matsushita Haruo,Ito Yoshinori,Shirato Hiroki

Funder

National Cancer Center Research and Development Fund

Grants-in-Aid for Cancer Research

Health and Labour Sciences Research Grant for Clinical Research

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference18 articles.

1. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis;Palma;J Clin Oncol,2010

2. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403;Nagata;Int J Radiat Oncol Biol Phys,2015

3. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials;Chang;Lancet Oncol,2015